VitalConnect’s Wearable Helps Predict Heart Failure Hospitalization In LINK HF
Executive Summary
Results of the LINK HF study showed PhysIQ’s machine learning system and VitalConnect’s wearable monitor can accurately predict impending heart failure hospitalizations.
You may also be interested in...
JPM 2021: Boston Scientific, Abbott, Dexcom, Insulet, Silk Road Medical
The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the second day of the meeting.
Abbott Launches New App To Keep Heart Failure Patients Out Of The Hospital
The Merlin 10.0 update to Abbott’s its Merlin patient care network, which works with the CardioMEMS HF sensor system, allows physicians to communicate directly with patients.
ESC 2014 Shines Spotlight On The Future Of Cardiology
The cardiology sector, long known as one of the most innovative in medtech, has a new wave of technologies on the horizon that could help reinvigorate the sector and create new multibillion-dollar market opportunities for device manufacturers. We take a closer look at these technologies, which include vagal nerve stimulation, remote monitoring for heart failure, as well as innovation in the percutaneous coronary intervention space, all of which were all in the spotlight at the recent European Society of Cardiology Congress 2014 in Barcelona.